ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Foundation Formed to Support Fellowship Awards

June 11, 1999

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

Henles to Get Bristol-Myers $25,000 Award

March 23, 1979

Bush Nominates VA Official For HHS Deputy Secretary.

March 30, 2001

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

In Brief: Shingleton Probably Replacement For Marks On Panel; Connie Henke Heads Oncology Nurses

June 8, 1979